Generation Bio debuts with $25M A round

Gene therapy company Generation Bio Co. (Cambridge, Mass.) emerged from stealth mode with a $25 million series A round from Atlas Venture.

The newco is using its GeneWave platform to develop gene therapies delivered via closed-end DNA (ceDNA), which translocates from a cell's cytoplasm to its nucleus without the use of a viral capsid. ...